Longeveron reconstitutes audit committee board members
Longeveron Inc. reported that, after a director’s resignation in March led to a temporary failure to meet Nasdaq Listing Rule 5605(c)(2)(A) audit committee requirements, its Board has reconstituted the Audit Committee.
Rhea-AI Filing Summary
Longeveron Inc. reported that, after a director’s resignation in March led to a temporary failure to meet Nasdaq Listing Rule 5605(c)(2)(A) audit committee requirements, its Board has reconstituted the Audit Committee. Effective July 24, 2026, the committee consists of Dr. Deborah Ascheim, Ms. Leah Rush Cann, Dr. George Paletta and Ms. Ursula Ungaro.
The company states that each Audit Committee member qualifies as independent, and that Ms. Cann qualifies as an audit committee financial expert under Item 407(d)(5)(ii) of Regulation S-K and Nasdaq Listing Rule 5605(c)(2), aligning the committee’s composition with applicable listing standards.
Positive
- Audit Committee brought into alignment with Nasdaq standards by appointing four independent directors, including one audit committee financial expert, addressing a prior temporary noncompliance caused by a director resignation.
Negative
- None.
8-K Event Classification
Key Figures
Key Terms
Nasdaq Listing Rule 5605(c)(2)(A) regulatory
audit committee financial expert financial
Regulation S-K regulatory
emerging growth company regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What governance change did Longeveron (LGVN) disclose regarding its Audit Committee?
Why was Longeveron (LGVN) temporarily out of compliance with Nasdaq rules?
Who are the members of Longeveron’s reconstituted Audit Committee (LGVN)?
How does Longeveron (LGVN) describe the independence of its Audit Committee members?
What Nasdaq requirement is referenced in Longeveron’s (LGVN) Audit Committee update?
AI-generated analysis. How Rhea-AI works. Not financial advice.